ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements
Biogen Pharmachem Industries Limited submitted its 31st Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 29, 2026.
Biogen Pharmachem Industries Ltd has issued a notice for its 31st Annual General Meeting scheduled for September 29, 2026. The meeting will be held via video conferencing.
Biogen Pharmachem Industries Ltd reported revenue from operations of ₹0.4 Cr (-73.3% YoY) and net profit of ₹0.2 Cr (-84.6% YoY) for Q1 FY27.
Biogen Pharmachem Industries Ltd reported revenue from operations of ₹0.6 Cr (-57.1% YoY) and a net loss of ₹0.4 Cr for Q4 FY26.